Walleye Capital’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Walleye Capital’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-34,719	Closed	-$2.6K	–	5131
2023 Q1	$2.6K	Hold	34,719	–	–	﹤0.01%	3743
2022 Q4	$177	Hold	34,719	–	–	﹤0.01%	3112
2022 Q3	$3K	Hold	34,719	–	–	﹤0.01%	3032
2022 Q2	$4K	Sell	34,719 -100	-0.3%	-$20	﹤0.01%	2171
2022 Q1	$12K	Buy	+34,819	New	+$14.1K	﹤0.01%	2065

Walleye Capital's LVACW Position: Q2 2023 in Review

Walleye Capital sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 34,719 shares — an estimated $2.6K sold.

Walleye Capital first reported a position in LVACW in Q1 2022 and held it in 5 quarters. The position peaked at $12K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Walleye Capital reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Walleye Capital sold 34,719 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $2.6K.
Walleye Capital first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 5 quarters.
Walleye Capital's LAVA Medtech Acquisition Corp. Warrants position peaked at $12K in Q1 2022.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Walleye Capital's 13F filing for Q2 2023, filed 14 Aug 2023.